Literature DB >> 25466419

Risk factors for circumferential R1 resection after neoadjuvant radiochemotherapy and laparoscopic total mesorectal excision: a study in 233 consecutive patients with mid or low rectal cancer.

Clotilde Debove1, Léon Maggiori, Amélie Chau, Frédéric Kanso, Marianne Ferron, Yves Panis.   

Abstract

PURPOSE: This study aimed to identify risk factors for circumferential R1 resection (R1c) after neoadjuvant radiochemotherapy (RCT) and laparoscopic total mesorectal excision (TME) for mid or low rectal cancer. Better knowledge of pre- or intraoperative risk factors could possibly help for the management of these patients.
METHODS: Between 2005 and 2013, 233 consecutive patients undergoing laparoscopic TME for low or mid rectal cancer after RCT were included. R1c resection was defined as a circumferential margin ≤ 1 mm. Univariate and multivariate analyses were performed to identify independent risk factors for R1c.
RESULTS: Twenty-five patients had R1c resection (11%). In univariate analysis, low rectal cancer, anterior tumour, T4 on pretherapeutic magnetic resonance imaging (MRI), T4 and/or N+ on post-RCT MRI and operative time > 240 min were associated with a significantly increased risk of R1c resection. In multivariate analysis, only T4 on post-RCT MRI (odds ratio (OR) = 6.02 [1.06-33]; p = 0.043) and operative time >240 min. (OR = 5.4 [1.01-28.9]; p = 0.049) were identified as independent risk factors for R1c resection. The risk of R1c resection was 3% (n = 3/88), 10% (n = 5/51) or 38% (n = 3/8) when 0, 1 or 2 risk factors were present in the same patient, respectively.
CONCLUSION: Patients with T4 on MRI after RCT and/or operative time >240 min. seems to be at higher risk for R1c resection. In a pragmatic approach, we consider that systematic second MRI after RCT could help the surgeon, especially in area where circumferential margin is too short, in order to reduce this risk of R1 resection.

Entities:  

Mesh:

Year:  2014        PMID: 25466419     DOI: 10.1007/s00384-014-2080-y

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  25 in total

1.  Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer.

Authors:  A Wibe; P R Rendedal; E Svensson; J Norstein; T J Eide; H E Myrvold; O Søreide
Journal:  Br J Surg       Date:  2002-03       Impact factor: 6.939

2.  Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.

Authors:  E Kapiteijn; C A Marijnen; I D Nagtegaal; H Putter; W H Steup; T Wiggers; H J Rutten; L Pahlman; B Glimelius; J H van Krieken; J W Leer; C J van de Velde
Journal:  N Engl J Med       Date:  2001-08-30       Impact factor: 91.245

3.  Rectal cancer surgery with or without bowel preparation: The French GRECCAR III multicenter single-blinded randomized trial.

Authors:  Frederic Bretagnol; Yves Panis; Eric Rullier; Philippe Rouanet; Stephane Berdah; Bertrand Dousset; Guillaume Portier; Stephane Benoist; Jacques Chipponi; Eric Vicaut
Journal:  Ann Surg       Date:  2010-11       Impact factor: 12.969

4.  Chemotherapy with preoperative radiotherapy in rectal cancer.

Authors:  Jean-François Bosset; Laurence Collette; Gilles Calais; Laurent Mineur; Philippe Maingon; Ljiljana Radosevic-Jelic; Alain Daban; Etienne Bardet; Alexander Beny; Jean-Claude Ollier
Journal:  N Engl J Med       Date:  2006-09-14       Impact factor: 91.245

Review 5.  Prognostic factors after surgery for locally recurrent rectal cancer: an overview.

Authors:  M Caricato; D Borzomati; F Ausania; S Valeri; A Rosignoli; R Coppola
Journal:  Eur J Surg Oncol       Date:  2005-12-27       Impact factor: 4.424

Review 6.  [Recommendations for clinical practice. Therapeutic choices for rectal cancer. How should neoadjuvant therapies be chosen?].

Authors:  Guillaume Portier
Journal:  Gastroenterol Clin Biol       Date:  2007-01

7.  Local recurrence following total mesorectal excision for rectal cancer.

Authors:  G Arbman; E Nilsson; O Hallböök; R Sjödahl
Journal:  Br J Surg       Date:  1996-03       Impact factor: 6.939

8.  Multicenter Evaluation of Rectal cancer ReImaging pOst Neoadjuvant (MERRION) Therapy.

Authors:  Ann M Hanly; Elizabeth M Ryan; Ailín C Rogers; Deborah A McNamara; Robert D Madoff; Desmond C Winter
Journal:  Ann Surg       Date:  2014-04       Impact factor: 12.969

9.  Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203.

Authors:  Jean-Pierre Gérard; Thierry Conroy; Franck Bonnetain; Olivier Bouché; Olivier Chapet; Marie-Thérèse Closon-Dejardin; Michel Untereiner; Bernard Leduc; Eric Francois; Jean Maurel; Jean-François Seitz; Bruno Buecher; Rémy Mackiewicz; Michel Ducreux; Laurent Bedenne
Journal:  J Clin Oncol       Date:  2006-10-01       Impact factor: 44.544

10.  The mesorectum in rectal cancer surgery--the clue to pelvic recurrence?

Authors:  R J Heald; E M Husband; R D Ryall
Journal:  Br J Surg       Date:  1982-10       Impact factor: 6.939

View more
  4 in total

Review 1.  Is There Any Reason Not to Perform Standard Laparoscopic Total Mesorectal Excision?

Authors:  Zaher Lakkis; Yves Panis
Journal:  Clin Colon Rectal Surg       Date:  2017-11-27

2.  Operative Approach Does Not Impact Radial Margin Positivity in Distal Rectal Cancer.

Authors:  George Q Zhang; Rebecca Sahyoun; Miloslawa Stem; Brian D Lo; Ashwani Rajput; Jonathan E Efron; Chady Atallah; Bashar Safar
Journal:  World J Surg       Date:  2021-09-08       Impact factor: 3.352

Review 3.  Fluorescent-guided surgery for sentinel lymph node detection in gastric cancer and carcinoembryonic antigen targeted fluorescent-guided surgery in colorectal and pancreatic cancer.

Authors:  Floris A Vuijk; Denise E Hilling; J Sven D Mieog; Alexander L Vahrmeijer
Journal:  J Surg Oncol       Date:  2018-09-14       Impact factor: 3.454

4.  Influence of incorrect staging of colorectal carcinoma on oncological outcome: are we playing safely?

Authors:  Claudia Reali; Gabriele Bocca; Ian Lindsey; Oliver Jones; Chris Cunningham; Richard Guy; Bruce George; Stephen Boyce
Journal:  Updates Surg       Date:  2021-07-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.